Similar to GBM IDH-wildtype, over 80% of histologically high-grade F3T3 gliomas harbor concurrent gains of chromosome 7 and loss of chromosome 10 (+7/−10) and/or pTERT mutation [28]. The gene discussed is IDH2; the disease is central nervous system cancer.